Clinical Efficacy of Neoadjuvant Camrelizumab Plus Chemotherapy for Triple-Negative Breast Cancer and Tumor Immune Microenvironment Analysis: A Prospective-Retrospective Cohort Study.

AiRuiKa (camrelizumab) - Elevar Therapeutics

http://www.ncbi.nlm.nih.gov/pubmed/42609520

Chunhui Zheng; Chunjian Wang; Haiqiang Liu; Jiaxin Zhang; Pengfei Qiu; Xiangjing Meng; Xiao Sun; Xingchen Meng; Yongsheng Wang; Yuechen Wang; Zhaopeng Zhang; Zhiqiang Shi

Aug 19, 2026